We have a research program in place, developing chemical tools to probe glycan-binding proteins and we were working with our industry collaborators, Iceni Diagnostics, in the area of diagnostics.
Many viruses target glycans (sugars) at various points of their infection processes, and we have been trying to develop nanoscience tools to look at this. So, as the COVID pandemic emerged it was obvious for us to focus on this urgent challenge.
